Advances in Oligonucleotide Aptamers for NSCLC Targeting

Non-small-cell lung cancer (NSCLC) is the most common type of lung cancer worldwide, with the highest incidence in developed countries. NSCLC patients often face resistance to currently available therapies, accounting for frequent relapses and poor prognosis. Indeed, despite great recent advancement...

Descripción completa

Detalles Bibliográficos
Autores principales: Rotoli, Deborah, Santana-Viera, Laura, Ibba, Maria L., Esposito, Carla L., Catuogno, Silvia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7504093/
https://www.ncbi.nlm.nih.gov/pubmed/32842557
http://dx.doi.org/10.3390/ijms21176075

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7504093/
https://www.ncbi.nlm.nih.gov/pubmed/32842557
http://dx.doi.org/10.3390/ijms21176075

Ejemplares similares